ethosuximide has been researched along with Anemia, Hypoplastic in 6 studies
Ethosuximide: An anticonvulsant especially useful in the treatment of absence seizures unaccompanied by other types of seizures.
ethosuximide : A dicarboximide that is pyrrolidine-2,5-dione in which the hydrogens at position 3 are substituted by one methyl and one ethyl group. An antiepileptic, it is used in the treatment of absence seizures and may be used for myoclonic seizures, but is ineffective against tonic-clonic seizures.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We describe a case of aplastic anemia in an 8-year-old girl which was diagnosed 8 months after initiation of ethosuximide as treatment for absence seizures." | 2.39 | Aplastic anemia following therapy for absence seizures with ethosuximide. ( Dunn, NL; Heckel, JL; Massey, GV; Myer, EC; Russell, EC, 1994) |
| "Rare, serious adverse effects of antiepileptic drugs (AEDs) include hepatotoxicity and bone marrow suppression." | 2.38 | Routine laboratory monitoring for serious adverse effects of antiepileptic medications: the controversy. ( Wyllie, E; Wyllie, R, 1991) |
| "A girl, born in 1975, developed severe aplastic anemia in November 1982 while on ethosuximide monotherapy for petit mal epilepsy, about 3 months after starting the ethosuximide medication." | 1.27 | Aplastic anemia during ethosuximide medication. Treatment with bolus-methylprednisolone. ( Seip, M, 1983) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (66.67) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| LEHMANN, J | 1 |
| Seip, M | 1 |
| Massey, GV | 1 |
| Dunn, NL | 1 |
| Heckel, JL | 1 |
| Myer, EC | 1 |
| Russell, EC | 1 |
| Wyllie, E | 1 |
| Wyllie, R | 1 |
| Götze, C | 1 |
| Schäfer, KH | 1 |
| Gabriel, B | 1 |
| Gabriel, BJ | 1 |
| Olmer, J | 1 |
2 reviews available for ethosuximide and Anemia, Hypoplastic
| Article | Year |
|---|---|
Aplastic anemia following therapy for absence seizures with ethosuximide.
Topics: Anemia, Aplastic; Blood Cell Count; Bone Marrow Transplantation; Child; Drug Monitoring; Epilepsy, A | 1994 |
Routine laboratory monitoring for serious adverse effects of antiepileptic medications: the controversy.
Topics: Anemia, Aplastic; Anticonvulsants; Carbamazepine; Chemical and Drug Induced Liver Injury; Drug Monit | 1991 |
4 other studies available for ethosuximide and Anemia, Hypoplastic
| Article | Year |
|---|---|
[PANMYELOPATHY DUE TO THE TREATMENT OF RETROPULSIVE PETIT MAL EPILEPSY WITH SUXINUTIN AND ITS CURE].
Topics: Anemia; Anemia, Aplastic; Bone Marrow Diseases; Child; Epilepsy; Epilepsy, Absence; Ethosuximide; Hu | 1965 |
Aplastic anemia during ethosuximide medication. Treatment with bolus-methylprednisolone.
Topics: Anemia, Aplastic; Anti-Bacterial Agents; Blood Transfusion; Child; Epilepsy, Absence; Ethosuximide; | 1983 |
[Successful immunosuppressive treatment of a pancytopathy with positive LE phenomenon induced by ethosuccinimide].
Topics: Anemia, Aplastic; Antibodies, Antinuclear; Antigens; Antimetabolites; Autoantibodies; Azathioprine; | 1970 |
[Bone marrow aplasia in the course of anti-epileptic treatments].
Topics: Adolescent; Adult; Anemia, Aplastic; Child; Ethosuximide; Female; Humans; Hydantoins; Male; Oxyphenb | 1966 |